Search results
The pages "Helsinn" and '"Helsinn"' do not exist. You can create a draft and submit it for review or request that a redirect be created, but consider checking the search results below to see whether the topic is already covered.
- appetite-enhancing and anabolic effects which is under development by Helsinn Healthcare SA for the treatment of cancer cachexia and anorexia. Anamorelin...8 KB (667 words) - 11:07, 7 August 2023
- developed by Helsinn around 2001. In January 2003, Helsinn filed a provisional patent application on palonosetron. Over the next 10 years, Helsinn filed four...15 KB (1,212 words) - 16:50, 6 July 2024
- chemotherapy-induced nausea and vomiting. It is marketed and distributed by Helsinn Therapeutics. Netupitant is an NK1 receptor antagonist and palonosetron...10 KB (547 words) - 05:29, 6 July 2024
- developed by Novo Nordisk, and was investigated in phase II clinical trials by Helsinn Therapeutics for the treatment of postoperative ileus, but was discontinued...7 KB (478 words) - 11:20, 29 December 2023
- entered into an agreement with the Helsinn Group for the exclusive distribution and license rights to the Helsinn Group's drug anamorelin in Spain, Portugal...8 KB (816 words) - 11:09, 19 February 2024
- 17–5554 January 15, 2019 New Prime Inc. v. Oliveira 17–340 January 15, 2019 Helsinn Healthcare S. A. v. Teva Pharmaceuticals USA, Inc. 17–1229 January 22,...4 KB (123 words) - 02:36, 13 September 2023
- Global headquarters GlaxoSmithKline Münchenbuchsee Bern Local headquarters Helsinn Lugano Ticino Global headquarters Hocoma Volketswil Zürich Global headquarters...13 KB (690 words) - 03:24, 15 July 2024
- Prime Inc. v. Oliveira, 586 U.S. ___ October 3, 2018 January 15, 2019 10 Helsinn Healthcare S. A. v. Teva Pharmaceuticals USA, Inc., 586 U.S. ___ December...62 KB (158 words) - 01:41, 13 September 2023
- Pharmaceutical signs a licensing agreement for new antiemetic palonosetron with Helsinn Healthcare SA (Switzerland) Research results on UFT adjuvant therapy for...11 KB (1,200 words) - 21:49, 15 December 2023
- public domain. "BridgeBio Pharma's Affiliate QED Therapeutics and Partner Helsinn Group Announce FDA Approval of Truseltiq (infigratinib) for Patients with...13 KB (822 words) - 23:20, 15 August 2024
- (netupitant/palonosetron), for nausea and vomiting, licensed by Eisai Co. and Helsinn Therapeutics. Alecensa (alectinib), for ALK-positive non-small cell lung...56 KB (5,124 words) - 17:16, 10 August 2024
- January 2019, the Supreme Court of the United States decided for Teva in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc. On May 11, 2019, Teva...69 KB (5,667 words) - 16:06, 15 August 2024
- strong control over selling. The original manufacturer of nimesulide is Helsinn Healthcare SA, Switzerland, which acquired the rights for the drug in 1976...18 KB (1,753 words) - 20:40, 17 July 2024
- • definition of "physical force" Breyer, Alito, Gorsuch, Kavanaugh 105 Helsinn Healthcare S. A. v. Teva Pharmaceuticals USA, Inc. 586 U.S. ___ (2019)...22 KB (47 words) - 15:00, 26 May 2024
- 1348 2018 WesternGeco LLC v. ION Geophysical Corp. 138 S.Ct. 2129 2018 Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc. 139 S.Ct. 628 2019 Return...45 KB (90 words) - 19:07, 16 August 2023
- 1007/s13539-010-0002-6. ISSN 2190-6009. PMC 3060651. PMID 21475699. Group, Helsinn. "Helsinn Initiates Extension Study in Late-Stage Anamorelin Clinical Program...25 KB (2,630 words) - 05:08, 15 July 2024
- (2009), Ebert and Schmid, Chapter 17: Inhaled Anesthetics, pp. 413–43 Helsinn Birex Therapeutics Ltd (2009). "By-Mycin 50mg capsules". medicines.ie:...50 KB (4,664 words) - 03:52, 14 August 2024
- ZP2929 Diabetes/Obesity Phase I ZEAL& ELSIGLUTIDE Chemotherapy Induced diarrhea Phase II HELSINN ZP1480(ABT-719) Acute kidney damage Phase II Abbvie...9 KB (657 words) - 09:10, 13 March 2024
- PMID 21652148. "BridgeBio Pharma's Affiliate QED Therapeutics and Partner Helsinn Group Announce FDA Approval of Truseltiq (infigratinib) for Patients with...74 KB (7,649 words) - 05:26, 16 August 2024
- GenScript Glenmark Pharmaceuticals Global Pharma Tek Grace Therapeutics Helsinn Heritage Pharmaceuticals Hovione Hudson BioPharma Immunomedics Impax Laboratories...20 KB (1,296 words) - 08:38, 16 August 2024
- Helsinn Healthcare S. A. v. Teva Pharmaceuticals USA, Inc., et al. (2019) Supreme Court of the United States 2685599Helsinn Healthcare S. A. v. Teva Pharmaceuticals